Could a smart antibody boost chemo for head and neck cancer?
Disease control
Completed
This phase 3 trial tested whether adding a targeted antibody (cetuximab) to standard chemotherapy (cisplatin) helps people with advanced head and neck cancer that has spread or come back. About 120 patients received either cisplatin plus cetuximab or cisplatin plus a placebo. The…
Phase: PHASE3 • Sponsor: Eastern Cooperative Oncology Group • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC